Henogen opens new biopharmaceutical clinical supply plant
The new biopharmaceutical clinical supply plant of Henogen was inaugurated today in a ceremony attended by the Wallonia Minister-President Jean-Claude Van Cauwenberghe. "These new cGMP facilities, dedicated to the mammalian cells culture, represent a total investment of 10 million Euros", said Dr Alex Bollen, CEO ; "they feature a park of 3L & 15L bioreactors used for process development purposes and a cGMP 300L bioreactor train, operated in both fed-batch and perfusion modes, able to deliver clinical-grade biologicals at a scale appropriate to the phase I to III clinical trials", he added.
This investment extends the existing know-how of Henogen 'from gene to clinical product' to the large scale production of clinical grade monoclonal antibodies and recombinant proteins made by mammalian cells, which is a very fast growing market.
These new facilities will generate additional revenues to the existing ones (forecast 2004: 7 MEUR) in order to boost the clinical development of its proprietary products e.g. a recombinant human tissue factor derivative, currently in clinical trials as well as other undisclosed programs.
Topics
Organizations
Other news from the department manufacturing
These products might interest you

Flexcell Zelldehnungsbioreaktoren für zelluläre Biomechanik-Anwendungen by Dunn
Cell Stretching Bioreactors for Life Science Research
Used in over 1300 laboratories worldwide, and cited in over 9000 research publications

Biostat STR by Sartorius
Biostat STR Generation 3 Bioreactors
Engineered for Ultimate Upstream Performance

Ambr® 250 HT Consumables by Sartorius
Efficient bioprocesses with single-use bioreactors
Minimise cleaning effort and maximise flexibility for cell and microbial cultures

Ambr® 250 Modular by Sartorius
Mini bioreactors for cell and gene therapies with high scalability
Maximise your process development with reliable single-use vessels

Flexcell Systems by Dunn
Flexcell Cell Stretching Bioreactors for Life Science Research
Used in over 1300 laboratories worldwide, and cited in over 4000 research publications

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous

Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous